180 related articles for article (PubMed ID: 27814399)
1. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
Balzano G; Dugnani E; Gandolfi A; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
PLoS One; 2016; 11(11):e0166008. PubMed ID: 27814399
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
[TBL] [Abstract][Full Text] [Related]
3. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
[TBL] [Abstract][Full Text] [Related]
4. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
5. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
[TBL] [Abstract][Full Text] [Related]
7. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.
Ben Q; Xu M; Jiang Y; Yuan Y; Wang K; Fang J; Li Z
Diabetes Metab Res Rev; 2012 Feb; 28(2):169-76. PubMed ID: 22423386
[TBL] [Abstract][Full Text] [Related]
9. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer.
Hank T; Sandini M; Qadan M; Weniger M; Ciprani D; Li A; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Pancreatology; 2020 Jan; 20(1):125-131. PubMed ID: 31706821
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
13. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
14. Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration.
Souza JJ; Machado MC; Cunha JE; Jukemura J; Nery M; Wajchenberg BL; Pereira MA; Corrêa-Giannella ML; Giannella-Neto D
Pancreatology; 2007; 7(2-3):187-93. PubMed ID: 17592233
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis.
Lv X; Qiao W; Leng Y; Wu L; Zhou Y
PLoS One; 2017; 12(2):e0171370. PubMed ID: 28158300
[TBL] [Abstract][Full Text] [Related]
16. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
18. Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancreas Registry.
Honselmann KC; Elser Y; Boeckmann T; Bolm L; Winkel MT; Deichmann S; Braun R; Wellner UF; Keck T; Lapshyn H
Surgery; 2023 Sep; 174(3):674-683. PubMed ID: 37349251
[TBL] [Abstract][Full Text] [Related]
19. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
